# OnCo record nct06245356 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06245356/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06245356", "NCT06245356" ;
  schema:name "Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic Colorectal or Gastroesophageal Cancer"@en ;
  schema:alternateName "TRIFLUOX-DP"@en ;
  schema:description "A phase 2 trial of trifluridine/tipiracil, fOLFOX (5-FU, leucovorin, oxaliplatin), panitumumab, bevacizumab (glioblastoma use) and other drugs in colorectal cancer, run by UNICANCER, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06245356/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06245356> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest", "colorectal-deep-dive" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/rectal-cancer/>, <https://onco.cc/cancers/colon-cancer/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/monoclonal-antibody/>, <https://onco.cc/technologies/platinum/> ;
  onco:drugs <https://onco.cc/drugs/trifluridine-tipiracil/>, <https://onco.cc/drugs/folfox/>, <https://onco.cc/drugs/panitumumab/>, <https://onco.cc/drugs/bevacizumab-glioma/>, <https://onco.cc/drugs/trastuzumab/>, <https://onco.cc/drugs/nivolumab/> ;
  onco:companies <https://onco.cc/companies/servier/>, <https://onco.cc/companies/unicancer/> .